美国白宫：美国和英国承诺在药品及其原料方面就显著优惠待遇达成协议，前提是相关调查结果符合预期。

Core Viewpoint - The U.S. and the U.K. have committed to reaching an agreement on significant preferential treatment regarding pharmaceuticals and their raw materials, contingent upon the results of relevant investigations being favorable [1] Group 1 - The agreement aims to enhance cooperation between the U.S. and U.K. in the pharmaceutical sector [1] - The preferential treatment is expected to benefit both countries' pharmaceutical industries by potentially lowering costs and improving supply chain efficiency [1] - The outcome of the agreement is dependent on the findings of ongoing investigations, indicating a cautious approach to regulatory compliance [1]